Equillium Investor Relations Material
Latest events
R&D Day 2023
Equillium
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Equillium Inc
Access all reports
Equillium Inc. is a clinical-stage biotechnology company that focuses on developing therapeutics for severe autoimmune and inflammatory disorders that have high unmet medical needs. It leverages a deep understanding of immunobiology to create novel treatments. Equillium's pipeline includes innovative, first-in-class immunomodulatory assets targeting critical immuno-inflammatory pathways. It is headquartered in La Jolla, California, and its shares are listed on the Nasdaq.
Key slides for Equillium Inc
Corporate Presentation
Equillium Inc
Corporate Presentation
Equillium Inc
Latest articles
Companies That Had Their IPO in 2019: Bull Market and Tech Dominance
Discussing the stock and IPO market in 2019, and the factors that led to the overall bullish performance of stocks during the year.
3 May 2024
Microsoft's Journey to Becoming the World's Most Valuable Company
Explore Microsoft's rise from a garage startup to the world's most valuable company, highlighting Bill Gates' role in shaping the digital revolution.
3 May 2024
Bill Gates: The Man Who Put a Computer in Every Home
Explore the life of Bill Gates, from co-founding Microsoft to global philanthropy, and his lasting impact on the world.
2 May 2024
Ticker symbol
Country
🇺🇸 United States